REGENERON PHARMACEUTICALS, INC.·4

Dec 18, 4:02 PM ET

STAHL NEIL 4

4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 18, 2024

Insider Transaction Report

Form 4
Period: 2024-12-16
STAHL NEIL
SVP Res and Dev Sciences
Transactions
  • Tax Payment

    Common Stock

    2024-12-16$730.81/sh304$222,16648,829 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,849
  • Common Stock

    (indirect: By Trust)
    4,605

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT